Immatics
gen leveraging and cells | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
26 of 75
Related slides by other companies
MaxCyte
Investor Presentation
January 2024
enabled active clinical trials | MaxCyte
BioNTech
Results
May 2021
neo stim personalized targeted adoptive cell therapy addresses limitations of til cell therapy approaches | BioNTech
Exscientia
Investor Day
January 2024
inhibition leads to cell death | Exscientia
Exscientia
Investor Presentation
August 2023
inhibition leads to cell death | Exscientia
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights